A new health care model
Soon, you as a patient with a Manic Depression Illness can measure your own lithium level. Medimate makes this possible by introducing a Licetas Disposable Chip and a manageable device: the Medimate Multireader. By using the Medimate Multireader and the Licetas Disposable Chip, you get more control over your lithium treatment. As opposed to the current situation, self-checking has the following advantages:
- Check the lithium level in your blood yourself
You take over the periodical checks of your lithium level and within two minutes you have got the result. In case of doubt, it is now possible to check it yourself. This gives more confidence and can help you prevent intoxications. - The patient first
As a patient, you come first in your treatment, because you know how you feel better than anyone. - Less hospital visits
Periodical check-ups of your lithium level in the hospital are unnecessary. No long journeys and no long waiting times. - Measure anywhere and “always”
Whether it is at home, at work or on vacation, measurements can be taken anywhere. This provides a feeling of safety. In case of illness or after physical exertion, an extra check-up can also provide more security. The only thing you have to take into account is that you cannot measure the first 12 hours after medication. - Also together with your family
For some it feels better to do the measurementsn together with a trusted person.
Self-checking changes healthcare, or in other words, the healthcare model. This new healthcare model offers you a better quality of life, direct results, more freedom and less hassle in the hospital.
To introduce this new healthcare model, support is crucial. Especially from the providers of treatments. Therefore, Medimate has excellent contacts with the “Kenniscentrum Bipolaire Stoornissen” and the “Lithiumplus werkgroep”. Treatment providers from these prominent knowledge networks are closely involved in the development of Medimate.
Furthermore, the Patient Association “Voor Manisch Depressieven en Betrokkenen” (VMDB) believes self-checking is extremely important. Amongst other things, Medimate has approached over 500 patients via the VMDB to ask for their opinion on self-checking. The results of this research were taken into consideration for the further development of Medimate.
Besides psychiatrists and patients, the support of health insurance companies is vital. Several health insurance companies have already indicated a marked interest in the Medimate Multireader and they hope that this will decrease the number of intoxications significantly. Not only will this benefit the patients, but it is also financially attractive for the health insurance company.
The navigation bar on the left side of the screen will help you find the information you are looking for. If you feel that there is any information missing, we would be happy to hear about it.